S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000967464.72156.a7 |
| _version_ | 1797279816925315072 |
|---|---|
| author | Marius Bill Leo Ruhnke Sven Zukunft Silvia Schäfer Jan-Niklas Eckardt Sebastian Stasik Maher Hanoun Thomas Schroeder Lars Fransecky Björn Steffen Stefan W. Krause Sebastian Scholl Andreas Hochhaus Tim Sauer Sabrina Kraus Kerstin Schäfer-Eckart Martin Kaufmann Edgar Jost Tim H Brümmendorf Christoph Schliemann Jan-Henrik Mikesch Utz Krug Mathias Hänel Anke Morgner Markus Schaich Andreas Neubauer Roland Repp Dirk Niemann Ruth Seggewiss-Bernhardt Achim Meinhardt Johannes Kullmer Ulrich Kaiser Wolfgang Blau Alexander Kiani Götz Ulrich Grigoleit Aristoteles Giagounidis Alexander Wurm Heidi Altmann Jan Moritz Middeke Johannes Schetelig Carsten Müller-Tidow Friedrich Stölzel Claudia Baldus Uwe Platzbecker Hubert Serve Martin Bornhäuser Christian Thiede Christoph Röllig |
| author_facet | Marius Bill Leo Ruhnke Sven Zukunft Silvia Schäfer Jan-Niklas Eckardt Sebastian Stasik Maher Hanoun Thomas Schroeder Lars Fransecky Björn Steffen Stefan W. Krause Sebastian Scholl Andreas Hochhaus Tim Sauer Sabrina Kraus Kerstin Schäfer-Eckart Martin Kaufmann Edgar Jost Tim H Brümmendorf Christoph Schliemann Jan-Henrik Mikesch Utz Krug Mathias Hänel Anke Morgner Markus Schaich Andreas Neubauer Roland Repp Dirk Niemann Ruth Seggewiss-Bernhardt Achim Meinhardt Johannes Kullmer Ulrich Kaiser Wolfgang Blau Alexander Kiani Götz Ulrich Grigoleit Aristoteles Giagounidis Alexander Wurm Heidi Altmann Jan Moritz Middeke Johannes Schetelig Carsten Müller-Tidow Friedrich Stölzel Claudia Baldus Uwe Platzbecker Hubert Serve Martin Bornhäuser Christian Thiede Christoph Röllig |
| author_sort | Marius Bill |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:32:26Z |
| format | Article |
| id | doaj.art-4f60a7cb94af465e91534560db0cc6e5 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:32:26Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-4f60a7cb94af465e91534560db0cc6e52024-03-03T10:10:15ZengWileyHemaSphere2572-92412023-08-017e72156a710.1097/01.HS9.0000967464.72156.a7202308003-00040S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIAMarius Bill0Leo Ruhnke1Sven Zukunft2Silvia Schäfer3Jan-Niklas Eckardt4Sebastian Stasik5Maher Hanoun6Thomas Schroeder7Lars Fransecky8Björn Steffen9Stefan W. Krause10Sebastian Scholl11Andreas Hochhaus12Tim Sauer13Sabrina Kraus14Kerstin Schäfer-Eckart15Martin Kaufmann16Edgar Jost17Tim H Brümmendorf18Christoph Schliemann19Jan-Henrik Mikesch20Utz Krug21Mathias Hänel22Anke Morgner23Markus Schaich24Andreas Neubauer25Roland Repp26Dirk Niemann27Ruth Seggewiss-Bernhardt28Achim Meinhardt29Johannes Kullmer30Ulrich Kaiser31Wolfgang Blau32Alexander Kiani33Götz Ulrich Grigoleit34Aristoteles Giagounidis35Alexander Wurm36Heidi Altmann37Jan Moritz Middeke38Johannes Schetelig39Carsten Müller-Tidow40Friedrich Stölzel41Claudia Baldus42Uwe Platzbecker43Hubert Serve44Martin Bornhäuser45Christian Thiede46Christoph Röllig471 University Hospital Dresden, Department of Internal Medicine I, Dresden, Germany1 University Hospital Dresden, Department of Internal Medicine I, Dresden, Germany1 University Hospital Dresden, Department of Internal Medicine I, Dresden, Germany2 University Hospital of the Technische Universität Dresden, Mildred Scheel Early Career Center, Medical Clinic and Policlinic I, Dresden, Germany1 University Hospital Dresden, Department of Internal Medicine I, Dresden, Germany1 University Hospital Dresden, Department of Internal Medicine I, Dresden, Germany5 University of Duisburg-Essen, Department of Hematology, University Hospital Essen, Essen, Germany5 University of Duisburg-Essen, Department of Hematology, University Hospital Essen, Essen, Germany6 University Hospital Schleswig-Holstein, Campus Kiel, Department of Hematology and Oncology, Kiel, Germany7 University Hospital Frankfurt, Department of Internal Medicine II, Frankfurt, Germany8 Universitätsklinikum Erlangen, Department of Internal Medicine V, Erlangen, Germany9 University Hospital Jena, Department of Internal Medicine II, Hematology and Medical Oncology, Jena, Germany9 University Hospital Jena, Department of Internal Medicine II, Hematology and Medical Oncology, Jena, Germany10 University of Heidelberg, Department of Internal Medicine V, Heidelberg, Germany11 University Hospital Würzburg, Department of Internal Medicine II, Würzburg, Germany12 Nuremberg Hospital North, Paracelsus Medical University, Department of Internal Medicine V, Nuremberg, Germany13 Robert-Bosch-Krankenhaus, Department of Hematology, Stuttgart, Germany14 University Hospital Aachen, Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Aachen, Germany14 University Hospital Aachen, Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Aachen, Germany16 University Hospital Münster, Department of Medicine A, Münster, Germany14 University Hospital Aachen, Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Aachen, Germany17 Klinikum Leverkusen, Department of Medicine 3, Leverkusen, Germany18 Chemnitz Hospital, Department of Internal Medicine III, Chemnitz, Germany18 Chemnitz Hospital, Department of Internal Medicine III, Chemnitz, Germany19 Rems-Murr-Hospital, Department of Hematology, Oncology and Palliative Care, Winnenden, Germany20 University Hospital Marburg, Department of Internal Medicine, Hematology, Oncology and Immunology, Marburg, Germany21 Städtisches Krankenhaus Kiel, Department of Internal Medicine II, Kiel, Germany22 Gemeinschaftsklinikum Mittelrhein, Department of Hematology, Oncology and Palliative Care, Koblenz, Germany23 Sozialstiftung Bamberg, Department of Internal Medicine V, Bamberg, Germany24 Agaplesion Diakonieklinikum Rotenburg, Department of Hematology and Oncology, Rotenburg, Germany25 DIAKO Bremen, Department of Internal Medicine II, Bremen, Germany26 St. Bernward Hospital, Department of Hematology, Oncology and Immunology, Hildesheim, Germany27 Helios Dr. Horst Schmidt Klinikum Wiesbaden, Department of Internal Medicine III, Hematology, Oncology and Palliative Care, Wiesbaden, Germany28 Klinikum Bayreuth GmbH, Department of Hematology and Oncology, Bayreuth, Germany30 Helios Klinikum Duisburg, Department of Hematology and Oncology, Duisburg, Germany31 Marien Hospital Düsseldorf, Department of Medical Oncology, Hematology and Palliative Care, Düsseldorf, Germany1 University Hospital Dresden, Department of Internal Medicine I, Dresden, Germany1 University Hospital Dresden, Department of Internal Medicine I, Dresden, Germany1 University Hospital Dresden, Department of Internal Medicine I, Dresden, Germany1 University Hospital Dresden, Department of Internal Medicine I, Dresden, Germany10 University of Heidelberg, Department of Internal Medicine V, Heidelberg, Germany6 University Hospital Schleswig-Holstein, Campus Kiel, Department of Hematology and Oncology, Kiel, Germany6 University Hospital Schleswig-Holstein, Campus Kiel, Department of Hematology and Oncology, Kiel, Germany33 University Hospital Leipzig, Department of Internal Medicine I, Hematology and Cellular Therapy, Leipzig, Germany7 University Hospital Frankfurt, Department of Internal Medicine II, Frankfurt, Germany1 University Hospital Dresden, Department of Internal Medicine I, Dresden, Germany1 University Hospital Dresden, Department of Internal Medicine I, Dresden, Germany1 University Hospital Dresden, Department of Internal Medicine I, Dresden, Germanyhttp://journals.lww.com/10.1097/01.HS9.0000967464.72156.a7 |
| spellingShingle | Marius Bill Leo Ruhnke Sven Zukunft Silvia Schäfer Jan-Niklas Eckardt Sebastian Stasik Maher Hanoun Thomas Schroeder Lars Fransecky Björn Steffen Stefan W. Krause Sebastian Scholl Andreas Hochhaus Tim Sauer Sabrina Kraus Kerstin Schäfer-Eckart Martin Kaufmann Edgar Jost Tim H Brümmendorf Christoph Schliemann Jan-Henrik Mikesch Utz Krug Mathias Hänel Anke Morgner Markus Schaich Andreas Neubauer Roland Repp Dirk Niemann Ruth Seggewiss-Bernhardt Achim Meinhardt Johannes Kullmer Ulrich Kaiser Wolfgang Blau Alexander Kiani Götz Ulrich Grigoleit Aristoteles Giagounidis Alexander Wurm Heidi Altmann Jan Moritz Middeke Johannes Schetelig Carsten Müller-Tidow Friedrich Stölzel Claudia Baldus Uwe Platzbecker Hubert Serve Martin Bornhäuser Christian Thiede Christoph Röllig S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA HemaSphere |
| title | S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA |
| title_full | S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA |
| title_fullStr | S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA |
| title_full_unstemmed | S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA |
| title_short | S138: VALIDATION OF THE REVISED 2022 EUROPEAN LEUKEMIANET (ELN) RISK STRATIFICATION IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA |
| title_sort | s138 validation of the revised 2022 european leukemianet eln risk stratification in adult patients with acute myeloid leukemia |
| url | http://journals.lww.com/10.1097/01.HS9.0000967464.72156.a7 |
| work_keys_str_mv | AT mariusbill s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT leoruhnke s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT svenzukunft s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT silviaschafer s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT janniklaseckardt s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT sebastianstasik s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT maherhanoun s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT thomasschroeder s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT larsfransecky s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT bjornsteffen s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT stefanwkrause s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT sebastianscholl s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT andreashochhaus s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT timsauer s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT sabrinakraus s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT kerstinschafereckart s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT martinkaufmann s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT edgarjost s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT timhbrummendorf s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT christophschliemann s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT janhenrikmikesch s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT utzkrug s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT mathiashanel s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT ankemorgner s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT markusschaich s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT andreasneubauer s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT rolandrepp s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT dirkniemann s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT ruthseggewissbernhardt s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT achimmeinhardt s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT johanneskullmer s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT ulrichkaiser s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT wolfgangblau s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT alexanderkiani s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT gotzulrichgrigoleit s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT aristotelesgiagounidis s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT alexanderwurm s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT heidialtmann s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT janmoritzmiddeke s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT johannesschetelig s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT carstenmullertidow s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT friedrichstolzel s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT claudiabaldus s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT uweplatzbecker s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT hubertserve s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT martinbornhauser s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT christianthiede s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia AT christophrollig s138validationoftherevised2022europeanleukemianetelnriskstratificationinadultpatientswithacutemyeloidleukemia |